Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov 1;7(1):1201-1235.
doi: 10.3233/ADR-230042. eCollection 2023.

A Systematic Review on Retinal Biomarkers to Diagnose Dementia from OCT/OCTA Images

Affiliations

A Systematic Review on Retinal Biomarkers to Diagnose Dementia from OCT/OCTA Images

Yehia Ibrahim et al. J Alzheimers Dis Rep. .

Abstract

Background: Traditional methods for diagnosing dementia are costly, time-consuming, and somewhat invasive. Since the retina shares significant anatomical similarities with the brain, retinal abnormalities detected via optical coherence tomography (OCT) and OCT angiography (OCTA) have been studied as a potential non-invasive diagnostic tool for neurodegenerative disorders; however, the most effective retinal changes remain a mystery to be unraveled in this review.

Objective: This study aims to explore the relationship between retinal abnormalities in OCT/OCTA images and cognitive decline as well as evaluating biomarkers' effectiveness in detecting neurodegenerative diseases.

Methods: A systematic search was conducted on PubMed, Web of Science, and Scopus until December 2022, resulted in 64 papers using agreed search keywords, and inclusion/exclusion criteria.

Results: The superior peripapillary retinal nerve fiber layer (pRNFL) is a trustworthy biomarker to identify most Alzheimer's disease (AD) cases; however, it is inefficient when dealing with mild AD and mild cognitive impairment (MCI). The global pRNFL (pRNFL-G) is another reliable biomarker to discriminate frontotemporal dementia from mild AD and healthy controls (HCs), moderate AD and MCI from HCs, as well as identifing pathological Aβ42/tau in cognitively healthy individuals. Conversely, pRNFL-G fails to realize mild AD and the progression of AD. The average pRNFL thickness variation is considered a viable biomarker to monitor the progression of AD. Finally, the superior and average pRNFL thicknesses are considered consistent for advanced AD but not for early/mild AD.

Conclusions: Retinal changes may indicate dementia, but further research is needed to confirm the most effective biomarkers for early and mild AD.

Keywords: Alzheimer’s disease; dementia; mild cognitive impairment; neurodegenerative disorders; optical coherence tomography; optical coherence tomography angiography; retinal biomarkers.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflict of interest to report.

Figures

Fig. 1
Fig. 1
Literature review process flowchart.
Fig. 2
Fig. 2
Retinal layers in a spectral domain optical coherence tomography b-scan image: unlabeled (top), labelled (bottom).
Fig. 3
Fig. 3
Anatomic layers, previous and new optical coherence tomography angiography (OCTA) segmentation names [15]. PR, photoreceptor layer.
Fig. 4
Fig. 4
Examples of optical coherence tomography angiography (OCTA) scans: A1) superficial vascular complex (SVC), B1) deep vascular complex (DVC), C1) inner vascular complex (IVC), and their corresponding manual foveal avascular zone (FAZ) segmentation.
Fig. 5
Fig. 5
HD Angio Disc mode (optic disc) Report Layout Legend: a) Garway-Heath (GH) map [31]; b) Hemisphere Maps; 2) Angio Retina mode (macular) Report Layout Legend: c, d) Hemisphere and Quadrant Maps [32].
Fig. 6
Fig. 6
Microvascular network sections in superficial capillary plexuses (SCP) (adapted from [21]).

References

    1. World Health Organization, Dementia, WHO, https://www.who.int/news-room/fact-sheets/detail/dementia, Accessed December 16, 2022.
    1. NHS-UK, About dementia - dementia guide, NHS, https://www.nhs.uk/conditions/dementia/about/?tabname=about-dementia, Accessed April 6, 2022.
    1. NIA-scientists, How biomarkers help diagnose dementia,National Institute on Aging, https://www.nia.nih.gov/health/how-biomarkers-helpdiagnose-dementia, Accessed April 6, 2022.
    1. NHS-UK, MRI scan, https://www.nhs.uk/conditions/mriscan/, Accessed December 16, 2022.
    1. Mounsey A, Zeitler MR (2018) Cerebrospinal fluid biomarkers for detection of Alzheimer disease in patients with mild cognitive impairment. Am Fam Physician 97, 714–715. - PubMed

Publication types

LinkOut - more resources